India will likely restart exporting COVID-19 vaccines next year once it has immunized its own adult population, the head of a government expert panel said.
“Almost 60 countries are hardly having any access to vaccine and India should be able to provide a substantial portion in 2022,” N.K. Arora, chairman of the National Technical Advisory Group on Immunization in India, said in an interview with Bloomberg Television on Tuesday.
“As soon as we are through with our adult population, we should have sufficient vaccine to share with the rest of the world.”
India expects that six locally-developed shots will have been approved by the end of 2021, Arora said.
- World’s first COVID-19 DNA vaccine gets emergency use approval in India
- India in talks to buy 50 million doses of Pfizer COVID-19 vaccine, says WSJ report
- India extends ban on intl flights until August 31 as Delta COVID-19 variant spreads
- India to miss end-July vaccination target as Bharat Biotech lags in ramping up output
- India hopes for normal overseas movement of citizens, including Gulf
- India denies recent studies suggesting millions have died from COVID-19
- Over two-thirds of India has COVID-19 antibodies, many still vulnerable: Study